Cancer

Ovarian Cancer Research Alliance (OCRA) Champions Access and Equity in Ovarian Cancer and Gynecologic Cancer Awareness Month

NEW YORK, Sept. 3, 2024 /PRNewswire/ -- As Ovarian and Gynecologic Cancer Awareness Month begins, Ovarian Cancer Research Alliance (OCRA) is…

1 year ago

Navigating Cancer Accelerates Investments to Enhance Care Management Platform for Providers and Patients

Acquisition by OneOncology enables accelerated innovation in leading care management platform and patient reported outcomes tool, without additional cost to customers2,000…

1 year ago

The nervous system’s matchmaker

COLD SPRING HARBOR, N.Y., Sept. 3, 2024 /PRNewswire/ -- When you ask a rideshare app to find you a car, the…

1 year ago

AngioDynamics Announces CE Mark Approval in Europe for the Auryon System

Regulatory approval enables entry of Auryon Atherectomy System in European marketLATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative…

1 year ago

Kronos Bio Announces Participation in Medical and Investor Conferences in September

SAN MATEO, Calif., and CAMBRIDGE, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated…

1 year ago

Y-mAbs to Participate in Upcoming Investor Conferences in September

NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical…

1 year ago

Femasys to Participate in Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference

ATLANTA, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet…

1 year ago

Galectin Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

NORCROSS, Ga., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target…

1 year ago

Three Complete Responses in Azer-Cel Allogeneic CD19 CAR T Phase 1b Trial in Blood Cancer (Diffuse Large B-Cell Lymphoma)

10 patients have been treated to date with azer-cel in the Phase 1b diffuse large B-cell lymphoma (DLBCL) trial Cohort…

1 year ago

Aidoc Launches Seven New AI Solutions to Tackle Europe’s Healthcare Challenges

Aidoc's new CE-marked AI solutions make its offering one of the most comprehensive in the field, enabling rapid delivery of…

1 year ago